MIRA
INFORM REPORT
|
Report Date : |
01.12.2012 |
IDENTIFICATION DETAILS
|
Name : |
NUTRA SPECIALITIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
No.26, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
15.09.2005 |
|
|
|
|
Com. Reg. No.: |
18-057504 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 143.066
Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231TN2005PTC057504 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Neutraceuticals, Food Supplements, specialty chemicals and products of similar nature. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (26) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 280000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track. Profitability
of the company appears to be under severe pressure. There appear huge
accumulated losses recorded by the company. However, trade relations are
reported as fair. Business is active. Payments are reported to be slow. The company can be considered for business dealings with some
caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces
of its past autarkic policies remain. Economic liberalization, including industrial
deregulation, privatization of state-owned enterprises, and reduced controls on
foreign trade and investment, began in the early 1990s and has served to
accelerate the country's growth, which has averaged more than 7% per year since
1997. India's diverse economy encompasses traditional village farming, modern
agriculture, handicrafts, a wide range of modern industries, and a multitude of
services. Slightly more than half of the work force is in agriculture, but
services are the major source of economic growth, accounting for more than half
of India's output, with only one-third of its labor force. India has
capitalized on its large educated English-speaking population to become a major
exporter of information technology services and software workers. In 2010, the
Indian economy rebounded robustly from the global financial crisis - in large
part because of strong domestic demand - and growth exceeded 8% year-on-year in
real terms. However, India's economic growth in 2011 slowed because of persistently
high inflation and interest rates and little progress on economic reforms. High
international crude prices have exacerbated the government's fuel subsidy
expenditures contributing to a higher fiscal deficit, and a worsening current
account deficit. Little economic reform took place in 2011 largely due to
corruption scandals that have slowed legislative work. India's medium-term
growth outlook is positive due to a young population and corresponding low
dependency ratio, healthy savings and investment rates, and increasing
integration into the global economy. India has many long-term challenges that
it has not yet fully addressed, including widespread poverty, inadequate
physical and social infrastructure, limited non-agricultural employment
opportunities, scarce access to quality basic and higher education, and
accommodating rural-to-urban migration.
|
Source
: CIA |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
No.26, |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Sr. No.69, Chandrapadiya Village, Vinjamur Mandal, Nellore
District-524228, Andhra Pradesh, India |
|
Tel. No.: |
91-8629-214145/6 |
|
|
|
|
Chennai Office : |
No.4, Second Floor, |
|
Tel No.: |
91-44-42984141 |
|
Fax No.: |
91-44-42121880 |
|
|
|
|
US Office: |
200, |
|
Tel No.: |
001 770 916 1722 |
|
Fax No.: |
001 770 916 1933 |
DIRECTORS
AS ON 29.09.2011
|
Name : |
Mr. Ramamurthy Thyagarajan |
|
Designation : |
Director |
|
Address : |
12, |
|
Date of Birth/Age : |
25.08.1937 |
|
Date of Appointment : |
17.11.2007 |
|
DIN No.: |
00185036 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U99999MH1985PTC035149 |
CREDENTIAL
FINANCE LIMITED |
Director |
20/09/1996 |
20/09/1996 |
26/08/2009 |
Dormant |
NO |
|
2 |
U22219TN1993PLC025407 |
ECONOMIST
COMMUNICATIONS LIMITED |
Director |
11/06/2002 |
11/06/2002 |
- |
Active |
NO |
|
3 |
U72200TN2000PTC044605 |
SHRIRAM
CENTRE FOR LEARNING PRIVATE LIMITED |
Director |
02/01/2003 |
02/01/2003 |
20/11/2011 |
Active |
NO |
|
4 |
U67120TN1995PTC030953 |
ABUSHA
INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED |
Director |
08/07/2004 |
08/07/2004 |
26/05/2008 |
Active |
NO |
|
5 |
U85196TN2004PTC053577 |
LIFECELL
INTERNATIONAL PRIVATE LIMITED |
Director |
08/07/2004 |
08/07/2004 |
- |
Active |
NO |
|
6 |
U65929TN2004NPL053788 |
CONFEDERATION
OF INDIAN NON BANKING FINANCE ENTITIES |
Director |
21/07/2004 |
21/07/2004 |
- |
Active |
NO |
|
7 |
U66010AP2005PLC045616 |
SHRIRAM
LIFE INSURANCE COMPANY LIMITED |
Director |
15/03/2005 |
15/03/2005 |
10/12/2009 |
Active |
NO |
|
8 |
U66010RJ2006PLC029979 |
SHRIRAM
GENERAL INSURANCE COMPANY LIMITED |
Director |
28/07/2006 |
28/07/2006 |
10/11/2009 |
Active |
NO |
|
9 |
U65991TN2007PLC064133 |
TVS
CAPITAL FUNDS LIMITED |
Director |
20/08/2008 |
21/10/2007 |
- |
Active |
NO |
|
10 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Director |
30/09/2008 |
17/11/2007 |
- |
Active |
NO |
|
11 |
U85100TN2007PTC063975 |
TRI
CELL THERAPEUTICS PRIVATE LIMITED |
Director |
30/09/2008 |
03/12/2007 |
- |
Active |
NO |
|
12 |
L25209TN1986PLC013098 |
VICTORY
LAMINATIONS LIMITED |
Director |
01/11/2011 |
01/11/2011 |
- |
Active |
NO |
|
Name : |
Mr. Vallavanur Subramaniam Pattabiraman |
|
Designation : |
Whole Time Director |
|
Address : |
No.23, Padmavathiar Street, Gopalapuram, Chennai-600086, Tamilnadu,
India |
|
Date of Birth/Age : |
13.06.1948 |
|
Date of Appointment : |
15.09.2005 |
|
DIN No.: |
00784247 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name of the
Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company/ LLP
Status |
Defaulting
status |
|
1 |
U74210TN2002PTC049065 |
PRECIMAX TECH PRIVATE
LIMITED |
Director |
10/06/2002 |
10/06/2002 |
01/11/2007 |
Active |
|
|
2 |
U85196TN2004PTC053577 |
LIFECELL INTERNATIONAL
PRIVATE LIMITED |
Director |
28/06/2004 |
28/06/2004 |
- |
Active |
NO |
|
3 |
U67120TN1995PTC030953 |
ABUSHA
INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED |
Director |
08/07/2004 |
08/07/2004 |
26/05/2008 |
Active |
NO |
|
4 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Whole-time
director |
15/09/2005 |
15/09/2005 |
- |
Active |
NO |
|
5 |
U52311TN2005PTC057635 |
NEUTRA MARKETING
PRIVATE LIMITED |
Director |
27/09/2005 |
27/09/2005 |
- |
Dormant |
NO |
|
6 |
U85100TN2007PTC063975 |
TRI CELL
THERAPEUTICS PRIVATE LIMITED |
Director |
15/06/2007 |
15/06/2007 |
- |
Active |
NO |
|
7 |
L21012TZ2005PLC012260 |
SERVALAKSHMI
PAPER LIMITED |
Director
appointed in casual vacancy |
09/06/2012 |
09/06/2012 |
- |
Active |
NO |
|
Name : |
Mr. Mohan Reddy Enaganuri |
|
Designation : |
Director |
|
Address : |
G-2, Prashanth Nilayam Lecturers Colony, Maguntha Layout, |
|
Date of Birth/Age : |
24.06.1971 |
|
Date of Appointment : |
21.05.2010 |
|
DIN No.: |
02720838 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24297AP2009PTC064991 |
CHEMSYNTH
LABORATORIES PRIVATE LIMITED |
Director |
09/09/2009 |
09/09/2009 |
Active |
NO |
|
2 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Director |
29/09/2011 |
21/05/2010 |
Active |
NO |
|
3 |
U24232AP2010PTC069596 |
HATRI
PHARMA PRIVATE LIMITED |
Director |
21/07/2010 |
21/07/2010 |
Active |
NO |
|
4 |
U20296AP2012PTC080563 |
GREEN
GOLD BIO COAL PRIVATE LIMITED |
Director |
27/04/2012 |
27/04/2012 |
Active |
NO |
|
Name : |
Mr. Giridhar Gopal Pulleti |
|
Designation : |
Director |
|
Address : |
Flat No.302, Srirama N Layam Plot MIG 41/A, Vengalrao Nagar, |
|
Date of Birth/Age : |
10.08.1968 |
|
Date of Appointment : |
21.05.2010 |
|
DIN No.: |
01594062 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24232AP2007PTC052453 |
SANOVA
PHARMA CHEM PRIVATE LIMITED |
Director |
22/01/2007 |
22/01/2007 |
- |
Active |
NO |
|
2 |
L24230MH2006PLC158589 |
AANJANEYA
LIFECARE LIMITED |
Director |
04/05/2010 |
20/03/2010 |
- |
Active |
NO |
|
3 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Director |
29/09/2011 |
21/05/2010 |
- |
Active |
NO |
|
4 |
L65999MH1985PLC035113 |
FINAVENTURE
CAPITAL LIMITED |
Director |
30/09/2011 |
20/11/2010 |
- |
Active |
NO |
|
5 |
U24297AP2009PTC064991 |
CHEMSYNTH
LABORATORIES PRIVATE LIMITED |
Director |
03/01/2011 |
03/01/2011 |
03/04/2011 |
Active |
NO |
|
Name : |
Mr. Jayarama Ramanan |
|
Designation : |
Additional Director |
|
Address : |
Flat No.2 A, Sriniketan, Second street, Venus Colony, Alwarpet,
Chennai-600018, Tamilnadu, India |
|
Date of Birth/Age : |
02.07.1946 |
|
Date of Appointment : |
22.11.2010 |
|
DIN No.: |
00028252 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U85196TN2004PTC053577 |
LIFECELL
INTERNATIONAL PRIVATE LIMITED |
Whole-time
director |
28/06/2004 |
28/06/2004 |
- |
Active |
NO |
|
2 |
U67120TN1995PTC030953 |
ABUSHA
INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED |
Director |
08/07/2004 |
08/07/2004 |
26/05/2008 |
Active |
NO |
|
3 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Director |
29/09/2011 |
15/09/2005 |
- |
Active |
NO |
|
4 |
U52311TN2005PTC057635 |
NEUTRA
MARKETING PRIVATE LIMITED |
Director |
27/09/2005 |
27/09/2005 |
- |
Dormant |
NO |
|
5 |
U85100TN2007PTC063975 |
TRI
CELL THERAPEUTICS PRIVATE LIMITED |
Director |
15/06/2007 |
15/06/2007 |
- |
Active |
NO |
|
6 |
U25209TN1996PLC035849 |
GREEN
GOLD POLYMERS LIMITED |
Additional
director |
01/08/2007 |
01/08/2007 |
- |
Strike
off |
NO |
|
Name : |
Mr. Deepak Abhaya |
|
Designation : |
Additional Director |
|
Address : |
27, Mylairangathan Street, T Nagar, Chennai-600017, Tamilnadu, India |
|
Date of Birth/Age : |
12.04.1983 |
|
Date of Appointment : |
22.11.2010 |
|
DIN No.: |
02043654 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U67120TN1995PTC030953 |
ABUSHA
INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED |
Director |
30/09/2008 |
26/05/2008 |
Active |
NO |
|
2 |
U24111TN2000PTC044076 |
SANSKAR
CHEMICALS AND DRUGS PRIVATE LIMITED |
Director |
02/03/2009 |
02/03/2009 |
Active |
NO |
|
3 |
U72900TN2009PTC072512 |
ENGRID
GLOBAL PRIVATE LIMITED |
Director |
07/08/2009 |
07/08/2009 |
Active |
NO |
|
4 |
U24231TN2005PTC057504 |
NUTRA
SPECIALITIES PRIVATE LIMITED |
Director |
29/09/2011 |
22/11/2010 |
Active |
NO |
|
5 |
U55101TN2012PTC086654 |
PURPLETREE
HOTELS AND HOSPITALITY SERVICES PRIVATE LIMITED |
Director |
06/07/2012 |
06/07/2012 |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2011
|
Names of Shareholders |
No. of Shares |
|
Deepak Abhaya |
2723025 |
|
Usha Abhyakumar |
1236550 |
|
Abusha Investment and Management Service Private Limited |
1666000 |
|
Ajit Kumar Chordia |
5000 |
|
Ajit Kumar Jain |
14000 |
|
Anand Mul / Kapil Chordia |
20000 |
|
Anil Kumar (HUF) |
1750 |
|
Bharath Nahar |
1250 |
|
Bhaskar Rao C. |
7800 |
|
Dinesh Kumar (HUF) |
1750 |
|
Dinesh Kumar |
30000 |
|
Generex Pharmassist |
400000 |
|
Gyan Jain |
60000 |
|
Gyan Vimala |
120000 |
|
Jagannath S. |
2500 |
|
Kamini Rao |
100000 |
|
Kankaria Jay |
1000 |
|
Kankaria Vasanthi |
4000 |
|
Kankaria Vijay |
2500 |
|
Kankaria Vishal |
1250 |
|
Kumar Sunil Kumar (HUF) |
1750 |
|
PAI Yukbnuka MK. Paisavita |
600000 |
|
Pattabiraman |
230000 |
|
Prabha. R. Parekh |
50000 |
|
Rajesh Kumar (HUF) |
1750 |
|
Rajesh S. |
2500 |
|
Ramanan |
310000 |
|
Giridhar Gopal |
150000 |
|
Mohan Reddy |
150000 |
|
Jayaraman T. |
1330000 |
|
Kannan R. |
1663334 |
|
Thyagarajan R. T. |
1440000 |
|
Sangeeta Srisrimal |
14000 |
|
Sara Nathan S. |
9000 |
|
Shah Hansa P Shah |
135500 |
|
Shah Malti V Shah |
25000 |
|
Shah Saroj Bala.K.Shah |
62500 |
|
Sheela D. |
30000 |
|
Sheila / Raju Madukar Deshpande |
812497 |
|
Deepak Shah |
487132 |
|
Madan Bai |
30000 |
|
Ramesh Jain |
25000 |
|
Nomula Laxmi |
100000 |
|
Sunn Mutha |
248250 |
|
TOTAL
|
14306588 |
AS ON 29.09.2011
|
Equity Shares
Break Up |
Percentage of
Holding |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident
Indian(s) or Overseas Corporate bodies or Others |
10.82 |
|
Bodies corporate |
14.44 |
|
Directors or relatives of Directors |
43.61 |
|
Other top fifty shareholders |
31.13 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Neutraceuticals, Food Supplements,
specialty chemicals and products of similar nature. |
|
|
|
|
Products : |
·
Olmesartan Medoxomil ·
Diacerein ·
Tetracaine |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
Canara Bank, Kasturba Nagar Branch, Kasturba Nagar, Chennai - 600020, Tamilnadu, India |
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Srikanth and Shanthi Associates Chartered Accountants |
|
Address : |
No 9, |
|
PAN No.: |
AAOFS4951L |
CAPITAL STRUCTURE
AS ON 31.03.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
19500000 |
Equity Shares |
Rs.10/- each |
Rs. 195.000 Millions |
|
500000 |
Preference Shares |
Rs.10/- each |
Rs. 5.000 Millions |
|
|
TOTAL |
|
Rs. 200.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
14306588 |
Equity Shares |
Rs.10/- each |
Rs. 143.066
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
143.066 |
86.359 |
75.500 |
|
|
2] Share Application Money |
0.002 |
12.502 |
0.000 |
|
|
3] Reserves & Surplus |
72.500 |
44.146 |
35.849 |
|
|
4] (Accumulated Losses) |
(145.017) |
(114.530) |
(73.781) |
|
|
NETWORTH |
70.551 |
28.477 |
37.568 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
111.138 |
101.191 |
97.925 |
|
|
2] Unsecured Loans |
64.203 |
42.556 |
32.675 |
|
|
TOTAL BORROWING |
175.341 |
143.747 |
130.600 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
5.408 |
|
|
Other Liabilities |
7.671 |
5.902 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
253.563 |
178.126 |
173.576 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
181.366 |
147.194 |
143.488 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
59.809
|
33.920
|
34.733 |
|
|
Sundry Debtors |
48.729
|
11.266
|
4.040 |
|
|
Cash & Bank Balances |
4.165
|
5.253
|
3.630 |
|
|
Other Current Assets |
0.188
|
0.149 |
0.000 |
|
|
Loans & Advances |
5.929
|
5.106
|
5.985 |
|
Total
Current Assets |
118.820
|
55.694 |
48.388 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
43.690
|
22.902
|
11.707 |
|
|
Other Current Liabilities |
0.945
|
0.492
|
5.451 |
|
|
Provisions |
1.988
|
1.368
|
1.185 |
|
Total
Current Liabilities |
46.623
|
24.762 |
18.343 |
|
|
Net Current Assets |
72.197
|
30.932
|
30.045 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.043 |
|
|
|
|
|
|
|
|
TOTAL |
253.563 |
178.126 |
173.576 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
|
46.859 |
|
|
|
Other Income |
|
|
0.121 |
|
|
|
TOTAL (A) |
162.228 |
91.943 |
46.980 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Material Consumed |
|
|
40.567 |
|
|
|
Operational Expenses |
|
|
8.665 |
|
|
|
Personal Costs |
|
|
10.395 |
|
|
|
Administrative Expenses |
175.191 |
117.713 |
7.662 |
|
|
|
Foreign Exchange Fluctuation |
|
|
1.170 |
|
|
|
Director Remuneration |
|
|
1.200 |
|
|
|
Amortization of Preliminary Expenses |
|
|
0.019 |
|
|
|
Increased / (Decreased) in Stock |
|
|
(7.944) |
|
|
|
TOTAL (B) |
175.191 |
117.713 |
61.734 |
|
|
|
|
|
|
|
|
Less |
PROFIT
/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
(12.963) |
(25.770) |
(14.754) |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.000 |
0.000 |
15.677 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
(12.963) |
(25.770) |
(30.431) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
15.755 |
14.485 |
13.226 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
BEFORE TAX (E-F) (G) |
(28.718) |
(40.255) |
(43.657) |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
1.769 |
1.892 |
5.299 |
|
|
|
|
|
|
|
|
|
|
PROFIT / (LOSS)
AFTER TAX (G-H) (I) |
(30.487) |
(42.147) |
(48.956) |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
(2.13) |
-- |
-- |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
(18.79)
|
(45.84)
|
(104.21) |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
NA
|
(93.17) |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(9.57)
|
(13.29)
|
(22.75) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.41)
|
(1.41)
|
(1.16) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.15
|
5.92
|
3.96 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.55
|
2.25
|
2.64 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
No |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
HIGHLIGHTS OF FINANCIAL POSITION AND PROSPECTS:
The Sales has been growing nearly two fold on an year on year
basis; Rs. 48.600 Millions in 2009, Rs.87.000 Millions in 2010 and Rs 160.100
Millions in 2011.
Exports have also been growing; Rs 11.400 Millions in 2010
and Rs 72.400 Millions in and 2011. The company expects to reach Rs 200.000
Millions in 2012.
The Number of Products
developed and manufactured have gone up to 11 as under.
|
1 |
10 – DAB |
|
2 |
Policosanol |
|
3 |
Olmesartan |
|
4 |
Boswellic Acid |
|
5 |
Warfarin |
|
6 |
Tetracaine |
|
7 |
Diacerein |
|
8 |
Risperidone |
|
9 |
Sitagliptine |
|
10 |
Lacosamide |
|
11 |
Levetiracetam |
The Product Mix is being strengthened constantly through
additions to the existing range.
COMPANY’S FUTURE OUTLOOK:
The Financial year 2010-11 being the third year of commercial
operation, the company had stabilized its manufacturing process in various
products and efforts are being made for optimizing the process and other
production parameters.
Large Pharma Companies Domestic and Overseas have approved
the manufacturing facilities of NSPL indicating strong faith in production and
quality control measures being adopted by NSPL. Due to this, the Company
expects regular orders from its clients.
The Company has filed 5 DMFs for US, EU, Chinese and Korean Markets.
The products are set for triggering for FDA approval in the next 6 months and
company is confident of getting necessary approvals within the next 12 months
there on.
The Company has been audited by Drug Control Authority of
Korea, who have approved their production and documentation facilities.
The Company has also obtained by ISO Certification “ISO
9001:2008”.
With the optimization of production parameters, introduction
of other products and other constant measures the Company is hopeful of achieving
much better turnover and profitability in the FY 2011-12.
FORM 8
|
Corporate
identity number of the company |
U24231TN2005PTC057504 |
|
Name of the
company |
NUTRA
SPECIALITIES PRIVATE LIMITED |
|
Address of the registered
office or of the principal place of
business in |
No.26,Vandalur-Kelambakkam
Main Road, Keelakottaiyur, Chennai - 600048, Tamil Nadu, India |
|
This form is for |
Modification of
charge |
|
Charge identification
number of the charge to be modified |
10025740 |
|
Type of charge |
·
Book
debts ·
Movable
property (not being pledge) ·
Floating
charge ·
Others |
|
Particular of
charge holder |
Canara Bank, Kasturba Nagar Branch, Kasturba Nagar, Chennai - 600020, Tamilnadu, India |
|
Nature of
instrument creating charge |
Supplemental
Common Hypothecation Agreement |
|
Date of
instrument Creating the charge |
04.10.2012 |
|
Amount secured by
the charge |
Rs. 266.943
Millions |
|
Brief of the principal
terms an conditions and extent and operation of the charge |
Rate of interest As per the
agreement (Rate of interest is subject to change by the bank from time to
time) Terms of repayment As per the
Agreement Margin As per the Agreement Extent and operation of the charge Exclusive 1st
Charge Other Charge amount of
Rs.266.943 Millions comprising OCC/ODBD-Rs.30.000 Millions, LC-Rs.40.000
Millions, BG-Rs.100Lacs, PC/FDB/FBE-Rs.40.000 Millions, TL-Rs.145.100
Millions and canmobile-1.843 Millions. All other terms and conditions are as
per the agreement. All other terms and conditions are as per the agreement
and sanction letter from the Bank |
|
Short particulars
of the property charged (Including location of the property) |
Whole of the
existing securities including those acquired and or to be acquired out the
enhanced Credit Limits made available now, including whole of stocks Book Debts and Whole of Machinery More fully
described in the agreement enclosed This is in addition
to all other existing securities. |
|
Date of
instrument modifying the charge |
03.10.2012 |
|
Particulars of
the present modification |
Out of the
Existing Charge amount of Rs.266.943 Millions, Credit limits of Rs.265.100 Millions is further secured by properties given above
more fully described in the agreement enclosed . All other terms and
conditions of the original charge and the subsequent modifications remain
unchanged. |
FIXED ASSETS
·
Land
·
Building
·
Computer and Printer
·
Electrical Items
·
Furniture and Fixtures
·
Lab Equipments
·
Motor Car and Vehicles
·
Plant and Machinery
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 54.57 |
|
|
1 |
Rs. 87.48 |
|
Euro |
1 |
Rs. 70.88 |
INFORMATION DETAILS
|
Report Prepared by
: |
DPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
26 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.